PVCT: Management Comments on Importance of Recent Patent Allowance in India

By admin | January 31, 2008
Rating 3.00 out of 5
[?]

Submitted By Knobias ClipReport

Provectus Pharmaceuticals, Inc. (PVCT) recently received an allowance of its patent application in India covering its lead dermatology agent, PH-10, along with a number of related agents. The pending patent covers topical products for treatment of skin diseases such as psoriasis and eczema. Additionally, a range of active compounds are protected, each related to the active ingredient in PH-10.

More Here>

Comments